(Q48032854)

7 February 2018

title

Mapping CSF biomarker profiles onto NIA-AA guidelines for Alzheimer's disease (English)

1 reference

7 February 2018

0 references

1 reference

15

1 reference

7 February 2018

Dorothea Buck

5

object named as

Dorothea Buck

1 reference

7 February 2018

author name string

Panagiotis Alexopoulos

1

1 reference

7 February 2018

Jennifer Roesler

2

1 reference

7 February 2018

Nathalie Thierjung

3

1 reference

7 February 2018

Lukas Werle

4

1 reference

7 February 2018

Igor Yakushev

6

1 reference

7 February 2018

Lena Gleixner

7

1 reference

7 February 2018

Simone Kagerbauer

8

1 reference

7 February 2018

Marion Ortner

9

1 reference

7 February 2018

Timo Grimmer

10

1 reference

7 February 2018

Hubert Kübler

11

1 reference

7 February 2018

Jan Martin

12

1 reference

7 February 2018

Nikolaos Laskaris

13

1 reference

7 February 2018

Alexander Kurz

14

1 reference

7 February 2018

publication date

8 August 2015

1 reference

7 February 2018

European Archives of Psychiatry and Clinical Neuroscience

published in

1 reference

7 February 2018

volume

266

1 reference

7 February 2018

issue

7

1 reference

7 February 2018

page(s)

587-597

1 reference

7 February 2018

Changing concepts of Alzheimer disease.

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0628-7

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0628-7

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0628-7

Is the word 'biomarker' being properly used by proteomics research in neuroscience?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0628-7

Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0628-7

An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0628-7

Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50-89 years: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0628-7

Application of the National Institute on Aging-Alzheimer's Association AD criteria to ADNI

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0628-7

The National Institute on Aging-Alzheimer's Association research criteria for mild cognitive impairment due to Alzheimer's disease: predicting the outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0628-7

Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0628-7

Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0628-7

Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0628-7

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0628-7

Soluble amyloid precursor protein β as blood-based biomarker of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0628-7

Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0628-7

Amyloid cascade and tau pathology cerebrospinal fluid markers in mild cognitive impairment with regards to Alzheimer's disease cerebral metabolic signature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0628-7

Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0628-7

Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0628-7

Relationships between biomarkers in aging and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0628-7

Comparing predictors of conversion and decline in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0628-7

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0628-7

Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0628-7

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0628-7

Learning the parts of objects by non-negative matrix factorization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0628-7

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0628-7

Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0628-7

Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0628-7

Prevalence of mixed pathologies in the aging brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0628-7

Advances in the prevention of Alzheimer's disease and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0628-7

Soluble amyloid precursor proteins and secretases as Alzheimer's disease biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0628-7

Brain size and the compensation of Alzheimer's disease symptoms: a longitudinal cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0628-7

Limited agreement between biomarkers of neuronal injury at different stages of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0628-7

Personalized medicine in Alzheimer's disease and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0628-7

Machine learning-based method for personalized and cost-effective detection of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0628-7

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0628-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0628-7

Clinical and neurobiological correlates of soluble amyloid precursor proteins in the cerebrospinal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0628-7

[Cognitive reserve and its relevance for the prevention and diagnosis of dementia]

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26253588

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00406-015-0628-7

1 reference

7 February 2018

release_vy2msiy6jvbbnmqlvvfedswyty

Fatcat ID

0 references

1 reference

7 February 2018